通过在结核病治疗中补充Phyllanthus niruri,可能改变里法素的生物可用性
Mirhansyah Ardana1,2, Marlyn Dian Laksitorini3, Endang Lukitaningsih4
1Faculty of Pharmacy, Universitas Mulawarman, Samarinda, Indonesia.
Current drug metabolism
|February 12, 2025
概括
尼鲁里植物 (Phyllanthus niruri) 可能会改变利芬素的生物可用性,这可能会影响结核病治疗的有效性. 需要进一步的体内研究来确认与药物载体和调节蛋白的相互作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 自然产品 化学 化学
背景情况:
- 利芬素是一种关键的结核病 (TB) 药物,但耐药性需要改进治疗策略.
- 免疫调节剂正在探索提高结核病治疗疗效.
- 菲拉兰特斯·尼鲁里 (Phyllanthus niruri) 具有免疫调节性质和临床益处.
研究的目的:
- 审查Phyllanthus niruri补充剂对利芬素生物可用性的潜在影响.
- 评估Phyllanthus niruri通过药物载体相互作用可能如何影响瑞芬素的抗菌性能.
主要方法:
- 关于Phyllanthus niruri和利芬素相互作用的研究文献综述.
- 对Phyllanthus niruri的二次代谢物对药物载体 (P-gp,AADAC,OATP1B) 和核受体 (PXR,PPARα) 的已知影响进行分析.
- 与其他影响瑞芬素生物可用性的天然产品进行比较.
主要成果:
- 菲兰斯·尼鲁里 (Phyllanthus niruri) 可能通过抑制P-gp,AADAC和OATP1B来增加里法辛的生物可用性.
- 由于刺激PXR和PPARα,存在潜在的抗作用.
- 其他天然产品通过P-gp抑制或PXR激活对利芬素生物可用性表现出不同的影响.
结论:
- 菲兰斯·尼鲁里对利法素生物可用性的影响是复杂的,需要进一步研究.
- 药物运输体的协同抑制由Phyllanthus niruri可以增强利法素的疗效.
- 在生物系统中验证这些相互作用,体内研究是必不可少的.
更多相关视频
相关概念视频
Factors Influencing Bioavailability: First-Pass Elimination
6.1K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.1K
Drug Biotransformation: Overview
2.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Factors Influencing Drug Absorption: Disease States and Pharmacology
412
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
412
Factors Influencing Drug Absorption: Presystemic Elimination
176
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
176


